Abstract:The pool of microbes inhabiting our body is known as "microbiota" and their collective genomes as "microbiome". The colon is the most densely populated organ in the human body, although other parts, such as the skin, vaginal mucosa, or respiratory tract, also harbour specific microbiota. This microbial community regulates some important metabolic and physiological functions of the host, and drives the maturation of the immune system in early life, contributing to its homeostasis during life. Alterations of the intestinal microbiota can occur by changes in composition (dysbiosis), function, or microbiota-host interactions and they can be directly correlated with several diseases. The only disease in which a clear causal role of a dysbiotic microbiota has been demonstrated is the case of Clostridium difficile infections. Nonetheless, alterations in composition and function of the microbiota have been associated with several gastrointestinal diseases (inflammatory bowel disease, colorectal cancer, or irritable bowel syndrome), as well as extra-intestinal pathologies, such as those affecting the liver, or the respiratory tract (e.g., allergy, bronchial asthma, and cystic fibrosis), among others. Species of Bifidobacterium genus are the normal inhabitants of a healthy human gut and alterations in number and composition of their populations is one of the most frequent features present in these diseases. The use of probiotics, including bifidobacteria strains, in preventive medicine to maintain a healthy intestinal function is well documented. Probiotics are also proposed as therapeutic agents for gastrointestinal disorders and other pathologies. The World Gastroenterology Organization recently published potential clinical applications for several probiotic formulations, in which species of lactobacilli are predominant. This review is focused on probiotic preparations containing Bifidobacterium strains, alone or in combination with other bacteria, which have been tested in human clinical studies. In spite of extensive literature on and research into this topic, the degree of scientific evidence of the effectiveness of probiotics is still insufficient in most cases. More effort need to be made to design and conduct accurate human studies demonstrating the efficacy of probiotics in the prevention, alleviation, or treatment of different pathologies.

Bifidobacterium bifidum as an example of a specialized human gut commensal

Genomics and ecological overview of the genus Bifidobacterium

Diversity, ecology and intestinal function of bifidobacteria

Genomic and ecological approaches to identify the Bifidobacterium breve prototype of the healthy human gut microbiota

Gut Bifidobacteria Populations in Human Health and Aging

Ecology- and genome-based identification of the Bifidobacterium adolescentis prototype of the healthy human gut microbiota

Impact of Bifidobacterium longum Subspecies infantis on Pediatric Gut Health and Nutrition: Current Evidence and Future Directions

The Bifidogenic Effect Revisited-Ecology and Health Perspectives of Bifidobacterial Colonization in Early Life

Exploring Bifidobacterium species community and functional variations with human gut microbiome structure and health beyond infancy

Molecular cross-talk among human intestinal bifidobacteria as explored by a human gut model

Bifidobacterium Species Colonization in Infancy: A Global Cross-Sectional Comparison by Population History of Breastfeeding

Development of gut microbiota and bifidobacterial communities of neonates in the first 6 weeks and their inheritance from mother

Functional Genomic and Metabolic Studies of the Adaptations of a Prominent Adult Human Gut Symbiont, Bacteroides thetaiotaomicron, to the Suckling Period

The infant gut microbiota as the cornerstone for future gastrointestinal health

Characterization of a Bifidobacterium animalis subsp. lactis reference strain based on ecology and transcriptomics

Factors involved in the colonization and survival of bifidobacteria in the gastrointestinal tract

Bifidobacterium mechanisms of immune modulation and tolerance

Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals

Genomic and functional diversity of cultivated Bifidobacterium from human gut microbiota

Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis

Species- and Age/Generation-Dependent Adherence of Bifidobacterium bifidum to Human Intestinal Mucus In Vitro